Designation of High-Risk Foods for Tracing; Request for Comments and for Scientific Data and Information, 6596-6598 [2014-02255]
Download as PDF
6596
Federal Register / Vol. 79, No. 23 / Tuesday, February 4, 2014 / Notices
Web site at: https://innovation.cms.gov/
initiatives/. Paper copies can
be obtained by writing to Steven
Johnson at the address listed in the
ADDRESSES section of this notice.
II. Collection of Information
Requirements
The information collection
requirements associated with this notice
are subject to the Paperwork Reduction
Act of 1995; however, the information
collection requirements are currently
approved under the information
collection request associated with OMB
control number 0938–0880 entitled
‘‘Medicare Waiver Demonstration
Applicant.’’ Applicants must submit the
Medicare Waiver Demonstration
Application to be considered for this
program.
(Catalog of Federal Domestic Assistance
Program No. 93.773, Medicare—Hospital
Insurance; and Program No. 93.774,
Medicare—Supplementary Medical
Insurance Program)
Dated: August 20, 2013.
Marilyn Tavenner,
Administrator, Centers for Medicare &
Medicaid Services.
[FR Doc. 2014–02062 Filed 1–31–14; 4:15 pm]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–N–0053]
Designation of High-Risk Foods for
Tracing; Request for Comments and
for Scientific Data and Information
AGENCY:
Food and Drug Administration,
HHS.
Notice; request for comments
and for scientific data and information.
ACTION:
The Food and Drug
Administration (‘‘FDA’’ or ‘‘we’’) is
announcing the opening of a docket to
obtain comments and scientific data and
information that will help us to
implement the section of the FDA Food
Safety Modernization Act (FSMA) that
requires FDA to designate high-risk
foods. We are providing an opportunity
for interested parties to submit
comments and scientific data and
information that will help us develop
our process for implementing this
provision.
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
Submit electronic or written
comments and scientific data and
information by April 7, 2014.
ADDRESSES: You may submit comments
and scientific data and information,
DATES:
VerDate Mar<15>2010
20:14 Feb 03, 2014
Jkt 232001
identified by Docket No. FDA–2014–N–
0053, by any of the following methods:
Electronic Submissions
Submit electronic comments and
scientific data and information in the
following way:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments
and scientific data and information.
Written Submissions
Submit written submissions in the
following ways:
• Mail/Hand delivery/Courier (for
paper submissions): Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852.
Instructions: All submissions received
must include the Agency name and
Docket No. FDA–2014–N–0053 for this
notice. All comments and scientific data
and information received may be posted
without change to
https://www.regulations.gov, including
any personal information provided. For
additional information on submitting
comments and scientific data and
information, see the ‘‘Comments’’
heading of the SUPPLEMENTARY
INFORMATION section of this document.
Docket: For access to the docket to
read background documents or
comments and scientific data and
information received, go to
https://www.regulations.gov and insert
the docket number found in brackets in
the heading of this document into the
‘‘Search’’ box and follow the prompts
and/or go to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, Rm
1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT:
Sherri Dennis, Center for Food Safety
and Applied Nutrition (HFS–005), Food
and Drug Administration, 5100 Paint
Branch Pkwy., College Park, MD 20740,
240–402–1914.
SUPPLEMENTARY INFORMATION:
I. Background
A. FDA Food Safety Modernization Act
Provision Requiring Designation of
High-Risk Foods
On January 4, 2011, the President
signed the FDA Food Safety
Modernization Act (FSMA) (Pub. L.
111–353) into law. Section 204 of FSMA
requires, among other things, the
designation of high-risk foods.
Specifically, section 204(d)(2)(A) of
FSMA requires FDA to designate highrisk foods for which additional
recordkeeping requirements are
appropriate and necessary to protect the
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
public health, and to do so not later
than 1 year after the date of enactment
of FSMA (and thereafter, if necessary).
Section 204(d)(2)(B) requires FDA to
publish the list of high-risk foods on the
Internet Web site of FDA at the time
when FDA issues final rules to establish
the additional recordkeeping
requirements for high-risk foods.
Section 204(d)(2)(A) of FSMA
specifically states that the designation of
high-risk foods must be based on the: (1)
Known safety risks of a particular food,
including the history and severity of
foodborne illness outbreaks attributed to
such food, taking into consideration
foodborne illness data collected by the
Centers for Disease Control and
Prevention; (2) likelihood that a
particular food has a high potential risk
for microbiological or chemical
contamination or would support the
growth of pathogenic microorganisms
due to the nature of the food or the
processes used to produce such food; (3)
point in the manufacturing process of
the food where contamination is most
likely to occur; (4) likelihood of
contamination and steps taken during
the manufacturing process to reduce the
possibility of contamination; (5)
likelihood that consuming a particular
food will result in a foodborne illness
due to contamination of the food; and
(6) likely or known severity, including
health and economic impacts, of a
foodborne illness attributed to a
particular food.
Through this notice, we are
establishing a docket to provide an
opportunity for interested parties to
provide comments and scientific data
and information that will help us refine
our draft approach to identifying highrisk foods, as required by section
204(d)(2) of FSMA. Section I.B
summarizes our tentative draft approach
for the review and evaluation of data to
designate high-risk foods. Attached as a
reference to this notice is a draft
approach document in which we
describe the process and methodology
we are considering using for designating
high-risk foods. After reviewing
comments received in response to this
notice on the draft approach described
here, we plan to further revise the
approach as necessary. We also
anticipate that the approach will be
reviewed by scientific experts (‘‘peer
reviewed’’).
While section 204(d)(2)(A) of FSMA
includes a statutory deadline within 1
year of the enactment of FSMA, FDA is
issuing this notice to solicit comments
and scientific data and information that
will help us refine our draft approach to
identifying high-risk foods. In section
II.B, there are a number of specific
E:\FR\FM\04FEN1.SGM
04FEN1
Federal Register / Vol. 79, No. 23 / Tuesday, February 4, 2014 / Notices
topics on which we think various
stakeholders and the public at large
could provide valuable comments and
scientific data and information to assist
us in implementing section 204 of
FSMA. We anticipate that this input
will be critical to our effective
implementation of section 204 of FSMA.
mstockstill on DSK4VPTVN1PROD with NOTICES
B. Draft Approach To Implement
Section 204(d)(2) of FSMA—Designation
of High-Risk Foods
Data and information developed to
identify the most significant foodborne
contaminants, including data and
information regarding the number,
severity, and related costs of illnesses,
may be used as data inputs for the highrisk foods approach, where applicable
and appropriate.
The draft approach would use a
multicriteria decision analysis
approach, similar to that of Anderson et
al., 2011 (Ref. 1), to identify those foods
which should be designated as highrisk. This approach would use the
specific criteria identified in section
204(d)(2)(A) of FSMA and would
implement those criteria within a risk
model. For each of the food and hazard
pairs identified, we would determine a
total risk score by the weighted sum of
the score for each of the defined criteria.
For foods that have multiple risk scores
because they appear in the list
associated with more than one hazard,
we would determine the total score for
that food using each of the individual
food-hazard pair total risk scores.
Inclusion on the high-risk food list
would be based on the total risk score
for foods or food categories. We describe
our draft approach, criteria, and scoring
system, and provide examples, in the
document entitled ‘‘FDA’s Draft
Approach for Designating High-Risk
Foods as Required by Section 204 of
FSMA’’ (Ref. 2). Although the analysis
would encompass food-hazard pairs, we
do not anticipate this to be a foodhazard list but rather a food list. This
draft approach may be further refined
pending stakeholder input in response
to this notice.
II. Request for Comments and Scientific
Data and Information
We invite comments on the draft
approach outlined in section I.B and the
submission of scientific data and
information relevant to high-risk food
designation. We anticipate that this
general input, along with the more
specific input we solicit below, will
significantly assist the Agency in
fulfilling the requirements of section
204 of FSMA. In particular, we invite
comment, scientific data, and
information on the following topics:
VerDate Mar<15>2010
20:14 Feb 03, 2014
Jkt 232001
• Considering available data,
uncertainty with the data, and the
intended methods, what alternative
approaches should we consider to
identify high-risk foods?
• What additional criteria should we
consider, within the bounds of the
factors Congress mandated in section
204(d)(2)(A) of FSMA, to develop the
list of high-risk foods? For example, in
addition to the public health related
economic impact of foodborne illnesses,
which the draft approach takes into
account, should the approach include
nonpublic health economic impact
factors, such as costs related to
disruption in the food supply following
a foodborne illness outbreak? If so, how
should we determine these costs given
the variety of foods and different market
values for various foods?
• What changes should we consider
making to the scoring system to ensure
the range of possibilities for the foods
and hazards is comprehensive and to
enhance the scoring?
• What changes should we consider
making to the approach to better
evaluate risk associated with animal
food?
• The draft approach would equally
weight the criteria. Should individual
weights be assigned to each criterion? If
so, which criteria should receive more
weight and how should those weights
be assigned?
• The draft approach would utilize
the food categorization scheme used for
the Reportable Food Registry (Ref. 3).
What other practical alternatives to this
food categorization scheme should we
consider in light of the practical
constraints of evaluating individual
commodities?
• Adverse reactions may occur when
allergic consumers are exposed to foods
that contain undeclared allergens.
Undeclared allergens may be present in
a food through either mislabeling or
cross-contact during processing and
handling. Both situations present a risk
to allergic consumers because they lead
to incomplete or inaccurate product
labels. How should food allergens,
including the major food allergens
defined in the Food Allergen Labeling
and Consumer Protection Act of 2004
(Pub. L. 108–282, Title II) (milk, eggs,
fish, Crustacean shellfish, tree nuts,
peanuts, wheat, and soybeans), be
considered in the development of the
high-risk food list?
C. Additional Information and Data
Requested
We also are interested in the
following types of information and data:
• Scientific data and methods that
can be used to assess the public health
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
6597
impact of acute or chronic exposures to
pathogens and chemical contaminants
in human food or animal food. In
particular, scientific data and methods
related to chronic exposures to chemical
contaminants in food.
• For representative foods in each
food category or commodity group to be
evaluated:
Æ A list of the pathogens and
chemical contaminants likely to be
found in the food;
Æ The percentage prevalence of
contaminants in the food;
Æ The levels of contaminants in the
food;
Æ The point in the manufacturing
process where the contaminants are
likely to be introduced in the food; and
Æ The typical steps and control
measures taken in the manufacturing
process to reduce the possibility of
contamination of the food with the
pathogen or chemical contaminant.
III. Comments
Interested persons may submit either
electronic comments and scientific data
and information regarding this
document to https://www.regulations.gov
or written comments to the Division of
Dockets Management (see ADDRESSES). It
is only necessary to send one set of
comments and scientific data and
information. Identify comments and
scientific data and information with the
docket number found in brackets in the
heading of this document. Received
comments and scientific data and
information may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday, and
will be posted to the docket at https://
www.regulations.gov.
IV. References
The following references have been
placed on display in the Division of
Dockets Management (see ADDRESSES)
and may be seen by interested persons
between 9 a.m. and 4 p.m., Monday
through Friday, and are available
electronically at https://
www.regulations.gov. (FDA has verified
the Web site addresses in this reference
section, but we are not responsible for
any subsequent changes to the Web sites
after this document publishes in the
Federal Register).
1. Anderson, M., Jaykus, L.-A., Beaulieu, S.
et al. ‘‘Pathogen-produce pair attribution risk
ranking tool to prioritize fresh produce
commodity and pathogen combinations for
further evaluation (P3ARRT).’’ Food Control
22, (2011): 1865–1872. 10.1016/
j.foodcont.2011.04.028.
2. Food and Drug Administration. ‘‘FDA’s
Draft Approach for Designating High-Risk
Foods as Required by Section 204 of FSMA.’’
2013. Available at https://www.fda.gov/
E:\FR\FM\04FEN1.SGM
04FEN1
6598
Federal Register / Vol. 79, No. 23 / Tuesday, February 4, 2014 / Notices
downloads/Food/GuidanceRegulation/
FSMA/UCM380212.pdf.
3. Food and Drug Administration. ‘‘U.S.
Food and Drug Administration, Reportable
Food Summary Report, Definitions.’’
Available at https://www.fda.gov/downloads/
Food/FoodSafety/FoodSafetyPrograms/RFR/
UCM211534.pdf. Last Modified April 2012.
Dated: January 29, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014–02255 Filed 2–3–14; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing in the U.S. in accordance with
35 U.S.C. 209 and 37 CFR Part 404 to
achieve expeditious commercialization
of results of federally-funded research
and development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
FOR FURTHER INFORMATION CONTACT:
Licensing information and copies of the
U.S. patent applications listed below
may be obtained by writing to the
indicated licensing contact at the Office
of Technology Transfer, National
Institutes of Health, 6011 Executive
Boulevard, Suite 325, Rockville,
Maryland 20852–3804; telephone: 301–
496–7057; fax: 301–402–0220. A signed
Confidential Disclosure Agreement will
be required to receive copies of the
patent applications.
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
Nucleic Acid-based Compositions and
Methods for the Species-Specific
Detection of Pathogenic Candida Fungi
Description of Technology: This
invention pertains to the development
of oligonucleotides for the rapid nucleic
acid-based identification of the Candida
fungi species C. haemulonii, C. kefyr, C.
lambica, C. lusitaniae, C. norvegensis, C.
norvegica, C. rugosa, C. utilis, C.
viswanathii, C. zeylanoides, C.
dubliniensis, and C. pelliculosa within
biological samples. This identification is
accomplished by targeting the internally
transcribed spacer-2 (ITS2) region that is
specific for each species. The assay is
sensitive, specific and rapid.
VerDate Mar<15>2010
20:14 Feb 03, 2014
Jkt 232001
Implementation of the technology will
facilitate earlier specific diagnoses, and
lead to better antifungal therapy
implementation for infected patients.
Potential Commercial Applications:
• Directing antifungal drug therapy
for improved patient outcomes
• Detection, discrimination of
Candida species from biological samples
• Addressing secondary infections of
immunosuppressed individuals
Competitive Advantages:
• Easily adapted for use in kits
• High-throughput capable
• Rapid and cost-effective
Development Stage: In vitro data
available
Inventors: Christine J. Morrison, Errol
Reiss, Cheryl M. Elie, Timothy J. Lott
(all of CDC)
Publication: Shin JH, et al. Rapid
identification of up to three Candida
species in a single reaction tube by a 5’
exonuclease assay using fluorescent
DNA probes. J Clin Microbiol. 1999
Jan;37(1):165–70. [PMID 9854084]
Intellectual Property: HHS Reference
No. E–340–2013/0—
• PCT Application No. PCT/US1998/
015840 filed 30 Jul 1998, which
published as WO 1999/006596 on 11
Feb 1999
• US Patent No. 6,242,178 issued 05
Jun 2001
• Various international issued patents
Related Technologies:
• HHS Reference No. E–293–2013/0
• HHS Reference No. E–332–2013/0
• HHS Reference No. E–232–2013/0
• HHS Reference No. E–335–2013/0
• HHS Reference No. E–339–2013/0
Licensing Contact: Whitney Blair, J.D.
M.P.H.; 301–435–4937; whitney.blair@
nih.gov
Nucleic Acid-based Compositions and
Methods for the Detection of Pathogenic
Candida or Aspergillus Fungi Species
Description of Technology: This
invention pertains to the development
of oligonucleotides for the rapid nucleic
acid-based identification of Candida or
Aspergillus fungi species in biological
samples. This identification is
accomplished by the targeting the
internally transcribed spacer-2 (ITS2)
region that are unique to various
Candida species. The assay is sensitive,
specific and rapid. Implementation of
the technology will facilitate earlier
specific diagnoses, and lead to better
antifungal therapy implementation for
infected patients.
Potential Commercial Applications:
• Directing antifungal drug therapy
for improved patient outcomes
• Detection, discrimination of
Candida and Aspergillus species from
biological samples
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
• Addressing secondary infections of
immunosuppressed individuals
Competitive Advantages:
• Easily adapted for use in kits
• High-throughput capable
• Rapid and cost-effective
Development Stage: In vitro data
available
Inventors: Christine J. Morrison, Errol
Reiss, Brian Holloway, Jong Hee Shin
(all of CDC)
Publication: Shin JH, et al. Rapid
identification of up to three Candida
species in a single reaction tube by a 5’
exonuclease assay using fluorescent
DNA probes. J Clin Microbiol. 1999
Jan;37(1):165–70. [PMID 9854084]
Intellectual Property: HHS Reference
No. E–339–2013/0—
• PCT Application No. PCT/US1997/
016423 filed 15 Sep 1997, which
published as WO 1998/011257 on 19
Mar 1998
• US Patent No. 6,235,890 issued 22
May 2001
• Various international issued patents
Related Technologies:
• HHS Reference No. E–293–2013/0
• HHS Reference No. E–332–2013/0
• HHS Reference No. E–232–2013/0
• HHS Reference No. E–335–2013/0
Licensing Contact: Whitney Blair, J.D.
M.P.H.; 301–435–4937; whitney.blair@
nih.gov
Nucleic Acid Assays for the Detection
and Discrimination of Aspergillus
Fungi Species within Biological
Samples
Description of Technology: This
invention relates to assays for the
detection and species-specific
identification of Aspergillus fungi.
Accurate clinical diagnosis of
Aspergillus species has become
increasingly important as certain
species, such as A. terreus and A.
fumigatus, are resistant to specific
commonly employed antifungal
compounds. Most contemporary fungal
diagnostic methods are time-consuming
and inaccurate. This invention directly
addresses those inadequacies by
providing a method to rapidly and
accurately differentiate all medically
important species of Aspergillus based
on differences in the DNA sequences of
the internal transcribed spacer 1 region
of ribosomal DNA.
Potential Commercial Applications:
• Directing antifungal drug therapy
for improved patient outcomes
• Detection, discrimination of
Aspergillus species from biological
samples
• Addressing secondary infections of
immunosuppressed individuals or
asthmatics
Competitive Advantages:
E:\FR\FM\04FEN1.SGM
04FEN1
Agencies
[Federal Register Volume 79, Number 23 (Tuesday, February 4, 2014)]
[Notices]
[Pages 6596-6598]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-02255]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2014-N-0053]
Designation of High-Risk Foods for Tracing; Request for Comments
and for Scientific Data and Information
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; request for comments and for scientific data and
information.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (``FDA'' or ``we'') is
announcing the opening of a docket to obtain comments and scientific
data and information that will help us to implement the section of the
FDA Food Safety Modernization Act (FSMA) that requires FDA to designate
high-risk foods. We are providing an opportunity for interested parties
to submit comments and scientific data and information that will help
us develop our process for implementing this provision.
DATES: Submit electronic or written comments and scientific data and
information by April 7, 2014.
ADDRESSES: You may submit comments and scientific data and information,
identified by Docket No. FDA-2014-N-0053, by any of the following
methods:
Electronic Submissions
Submit electronic comments and scientific data and information in
the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments and scientific data and
information.
Written Submissions
Submit written submissions in the following ways:
Mail/Hand delivery/Courier (for paper submissions):
Division of Dockets Management (HFA-305), Food and Drug Administration,
5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
Instructions: All submissions received must include the Agency name
and Docket No. FDA-2014-N-0053 for this notice. All comments and
scientific data and information received may be posted without change
to https://www.regulations.gov, including any personal information
provided. For additional information on submitting comments and
scientific data and information, see the ``Comments'' heading of the
SUPPLEMENTARY INFORMATION section of this document.
Docket: For access to the docket to read background documents or
comments and scientific data and information received, go to https://www.regulations.gov and insert the docket number found in brackets in
the heading of this document into the ``Search'' box and follow the
prompts and/or go to the Division of Dockets Management (HFA-305), Food
and Drug Administration, 5630 Fishers Lane, Rm 1061, Rockville, MD
20852.
FOR FURTHER INFORMATION CONTACT: Sherri Dennis, Center for Food Safety
and Applied Nutrition (HFS-005), Food and Drug Administration, 5100
Paint Branch Pkwy., College Park, MD 20740, 240-402-1914.
SUPPLEMENTARY INFORMATION:
I. Background
A. FDA Food Safety Modernization Act Provision Requiring Designation of
High-Risk Foods
On January 4, 2011, the President signed the FDA Food Safety
Modernization Act (FSMA) (Pub. L. 111-353) into law. Section 204 of
FSMA requires, among other things, the designation of high-risk foods.
Specifically, section 204(d)(2)(A) of FSMA requires FDA to designate
high-risk foods for which additional recordkeeping requirements are
appropriate and necessary to protect the public health, and to do so
not later than 1 year after the date of enactment of FSMA (and
thereafter, if necessary). Section 204(d)(2)(B) requires FDA to publish
the list of high-risk foods on the Internet Web site of FDA at the time
when FDA issues final rules to establish the additional recordkeeping
requirements for high-risk foods.
Section 204(d)(2)(A) of FSMA specifically states that the
designation of high-risk foods must be based on the: (1) Known safety
risks of a particular food, including the history and severity of
foodborne illness outbreaks attributed to such food, taking into
consideration foodborne illness data collected by the Centers for
Disease Control and Prevention; (2) likelihood that a particular food
has a high potential risk for microbiological or chemical contamination
or would support the growth of pathogenic microorganisms due to the
nature of the food or the processes used to produce such food; (3)
point in the manufacturing process of the food where contamination is
most likely to occur; (4) likelihood of contamination and steps taken
during the manufacturing process to reduce the possibility of
contamination; (5) likelihood that consuming a particular food will
result in a foodborne illness due to contamination of the food; and (6)
likely or known severity, including health and economic impacts, of a
foodborne illness attributed to a particular food.
Through this notice, we are establishing a docket to provide an
opportunity for interested parties to provide comments and scientific
data and information that will help us refine our draft approach to
identifying high-risk foods, as required by section 204(d)(2) of FSMA.
Section I.B summarizes our tentative draft approach for the review and
evaluation of data to designate high-risk foods. Attached as a
reference to this notice is a draft approach document in which we
describe the process and methodology we are considering using for
designating high-risk foods. After reviewing comments received in
response to this notice on the draft approach described here, we plan
to further revise the approach as necessary. We also anticipate that
the approach will be reviewed by scientific experts (``peer
reviewed'').
While section 204(d)(2)(A) of FSMA includes a statutory deadline
within 1 year of the enactment of FSMA, FDA is issuing this notice to
solicit comments and scientific data and information that will help us
refine our draft approach to identifying high-risk foods. In section
II.B, there are a number of specific
[[Page 6597]]
topics on which we think various stakeholders and the public at large
could provide valuable comments and scientific data and information to
assist us in implementing section 204 of FSMA. We anticipate that this
input will be critical to our effective implementation of section 204
of FSMA.
B. Draft Approach To Implement Section 204(d)(2) of FSMA--Designation
of High-Risk Foods
Data and information developed to identify the most significant
foodborne contaminants, including data and information regarding the
number, severity, and related costs of illnesses, may be used as data
inputs for the high-risk foods approach, where applicable and
appropriate.
The draft approach would use a multicriteria decision analysis
approach, similar to that of Anderson et al., 2011 (Ref. 1), to
identify those foods which should be designated as high-risk. This
approach would use the specific criteria identified in section
204(d)(2)(A) of FSMA and would implement those criteria within a risk
model. For each of the food and hazard pairs identified, we would
determine a total risk score by the weighted sum of the score for each
of the defined criteria. For foods that have multiple risk scores
because they appear in the list associated with more than one hazard,
we would determine the total score for that food using each of the
individual food-hazard pair total risk scores. Inclusion on the high-
risk food list would be based on the total risk score for foods or food
categories. We describe our draft approach, criteria, and scoring
system, and provide examples, in the document entitled ``FDA's Draft
Approach for Designating High-Risk Foods as Required by Section 204 of
FSMA'' (Ref. 2). Although the analysis would encompass food-hazard
pairs, we do not anticipate this to be a food-hazard list but rather a
food list. This draft approach may be further refined pending
stakeholder input in response to this notice.
II. Request for Comments and Scientific Data and Information
We invite comments on the draft approach outlined in section I.B
and the submission of scientific data and information relevant to high-
risk food designation. We anticipate that this general input, along
with the more specific input we solicit below, will significantly
assist the Agency in fulfilling the requirements of section 204 of
FSMA. In particular, we invite comment, scientific data, and
information on the following topics:
Considering available data, uncertainty with the data, and
the intended methods, what alternative approaches should we consider to
identify high-risk foods?
What additional criteria should we consider, within the
bounds of the factors Congress mandated in section 204(d)(2)(A) of
FSMA, to develop the list of high-risk foods? For example, in addition
to the public health related economic impact of foodborne illnesses,
which the draft approach takes into account, should the approach
include nonpublic health economic impact factors, such as costs related
to disruption in the food supply following a foodborne illness
outbreak? If so, how should we determine these costs given the variety
of foods and different market values for various foods?
What changes should we consider making to the scoring
system to ensure the range of possibilities for the foods and hazards
is comprehensive and to enhance the scoring?
What changes should we consider making to the approach to
better evaluate risk associated with animal food?
The draft approach would equally weight the criteria.
Should individual weights be assigned to each criterion? If so, which
criteria should receive more weight and how should those weights be
assigned?
The draft approach would utilize the food categorization
scheme used for the Reportable Food Registry (Ref. 3). What other
practical alternatives to this food categorization scheme should we
consider in light of the practical constraints of evaluating individual
commodities?
Adverse reactions may occur when allergic consumers are
exposed to foods that contain undeclared allergens. Undeclared
allergens may be present in a food through either mislabeling or cross-
contact during processing and handling. Both situations present a risk
to allergic consumers because they lead to incomplete or inaccurate
product labels. How should food allergens, including the major food
allergens defined in the Food Allergen Labeling and Consumer Protection
Act of 2004 (Pub. L. 108-282, Title II) (milk, eggs, fish, Crustacean
shellfish, tree nuts, peanuts, wheat, and soybeans), be considered in
the development of the high-risk food list?
C. Additional Information and Data Requested
We also are interested in the following types of information and
data:
Scientific data and methods that can be used to assess the
public health impact of acute or chronic exposures to pathogens and
chemical contaminants in human food or animal food. In particular,
scientific data and methods related to chronic exposures to chemical
contaminants in food.
For representative foods in each food category or
commodity group to be evaluated:
[cir] A list of the pathogens and chemical contaminants likely to
be found in the food;
[cir] The percentage prevalence of contaminants in the food;
[cir] The levels of contaminants in the food;
[cir] The point in the manufacturing process where the contaminants
are likely to be introduced in the food; and
[cir] The typical steps and control measures taken in the
manufacturing process to reduce the possibility of contamination of the
food with the pathogen or chemical contaminant.
III. Comments
Interested persons may submit either electronic comments and
scientific data and information regarding this document to https://www.regulations.gov or written comments to the Division of Dockets
Management (see ADDRESSES). It is only necessary to send one set of
comments and scientific data and information. Identify comments and
scientific data and information with the docket number found in
brackets in the heading of this document. Received comments and
scientific data and information may be seen in the Division of Dockets
Management between 9 a.m. and 4 p.m., Monday through Friday, and will
be posted to the docket at https://www.regulations.gov.
IV. References
The following references have been placed on display in the
Division of Dockets Management (see ADDRESSES) and may be seen by
interested persons between 9 a.m. and 4 p.m., Monday through Friday,
and are available electronically at https://www.regulations.gov. (FDA
has verified the Web site addresses in this reference section, but we
are not responsible for any subsequent changes to the Web sites after
this document publishes in the Federal Register).
1. Anderson, M., Jaykus, L.-A., Beaulieu, S. et al. ``Pathogen-
produce pair attribution risk ranking tool to prioritize fresh
produce commodity and pathogen combinations for further evaluation
(P\3\ARRT).'' Food Control 22, (2011): 1865-1872. 10.1016/
j.foodcont.2011.04.028.
2. Food and Drug Administration. ``FDA's Draft Approach for
Designating High-Risk Foods as Required by Section 204 of FSMA.''
2013. Available at https://www.fda.gov/
[[Page 6598]]
downloads/Food/GuidanceRegulation/FSMA/UCM380212.pdf.
3. Food and Drug Administration. ``U.S. Food and Drug
Administration, Reportable Food Summary Report, Definitions.''
Available at https://www.fda.gov/downloads/Food/FoodSafety/FoodSafetyPrograms/RFR/UCM211534.pdf. Last Modified April 2012.
Dated: January 29, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014-02255 Filed 2-3-14; 8:45 am]
BILLING CODE 4160-01-P